BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: González A, Calfío C, Churruca M, Maccioni RB. Glucose metabolism and AD: evidence for a potential diabetes type 3. Alzheimers Res Ther 2022;14:56. [PMID: 35443732 DOI: 10.1186/s13195-022-00996-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G. Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease. Int J Mol Sci 2022;23. [PMID: 36555450 DOI: 10.3390/ijms232415811] [Reference Citation Analysis]
2 Xue Z, Ye L, Mao C, Lan Z, Ge J, Zhou X, Bao X, Yu L, Xu Y, Zhu X. ABHD6 inhibition alleviates memory deficits in an Alzheimer's disease mouse model.. [DOI: 10.21203/rs.3.rs-2088852/v1] [Reference Citation Analysis]
3 Kim J, Kang S, Chang K. Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model. IJMS 2022;23:10602. [DOI: 10.3390/ijms231810602] [Reference Citation Analysis]
4 Kumar V, Kim S, Bishayee K. Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions. IJMS 2022;23:9540. [DOI: 10.3390/ijms23179540] [Reference Citation Analysis]